Observational studyInflammopharmacology2023

High-dose intravenous anakinra treatment is safe and effective in severe and critical COVID-19 patients: a propensity score-matched study in a single center.

Murat Bektaş et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.